A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia  by Coutelier, Marie et al.
REPORT
A Recurrent Mutation in CACNA1G Alters
Cav3.1 T-Type Calcium-Channel Conduction
and Causes Autosomal-Dominant Cerebellar Ataxia
Marie Coutelier,1,2,3,4,5,6,19 Iulia Blesneac,7,8,19 Arnaud Monteil,7,8 Marie-Lorraine Monin,1,2,3,4,9
Kunie Ando,1,2,3,4,10 Emeline Mundwiller,4 Alfredo Brusco,11,12 Isabelle Le Ber,1,2,3,4,13
Mathieu Anheim,14,15,16 Anna Castrioto,17,18 Charles Duyckaerts,1,2,3,4,10 Alexis Brice,1,2,3,4,9
Alexandra Durr,1,2,3,4,9 Philippe Lory,7,8,20 and Giovanni Stevanin1,2,3,4,6,9,20,*
Hereditary cerebellar ataxias (CAs) are neurodegenerative disorders clinically characterized by a cerebellar syndrome, often accompanied by
other neurological or non-neurological signs. All transmissionmodes have been described. In autosomal-dominantCA (ADCA),mutations
inmore than30genes are implicated, but themolecular diagnosis remains unknown inabout40%of cases. Implicationof ion channels has
long been anongoing topic in the genetics of CA, andmutations in several channel genes have been recently connected toADCA. In a large
family affected by ADCA andmild pyramidal signs, we searched for the causative variant by combining linkage analysis andwhole-exome
sequencing. In CACNA1G, we identified a c.5144G>A mutation, causing an arginine-to-histidine (p.Arg1715His) change in the voltage
sensor S4 segmentof theT-type channel proteinCav3.1. Twooutof 479 index subjects screened subsequentlyharbored the samemutation.
We performed electrophysiological experiments in HEK293T cells to compare the properties of the p.Arg1715His and wild-type Cav3.1
channels. The current-voltage and the steady-state activation curves of the p.Arg1715His channelwere shifted positively, whereas the inac-
tivation curvehadahigher slope factor. Computermodeling indeep cerebellar nuclei (DCN)neurons suggested that themutation results in
decreasedneuronalexcitability. Taken together, thesedataestablishCACNA1G,which ishighlyexpressed in thecerebellum,asagenewhose
mutations can cause ADCA. This is consistent with the neuropathological examination, which showed severe Purkinje cell loss. Our study
further extends our knowledge of the link between calcium channelopathies and CAs.Hereditary cerebellar ataxias (CAs) are rare clinically and
genetically heterogeneous neurodegenerative disorders.1
They are characterized by a cerebellar syndrome, associated
with other neurological or extra-neurological symptoms,
and are inherited in all classical transmission modes. In
autosomal-dominant CAs (ADCAs), the most frequent mu-
tations are trinucleotide CAG-repeat expansions (present
in seven genes),2 coding for a polyglutamine stretch in
the corresponding proteins. The secondmost frequentmu-
tations are noncoding nucleotide expansions, followed by
conventional mutations that have been described in more
than 20 different genes. The causative variant remains
unknown, however, in about 40% of individuals with
ADCA.2,3
Over the last few years, next-generation sequencing has
led to the identification of an increasing number of
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pathways, including channels, have highlighted their
importance in the physiopathology of ADCAs. The first
channel-coding gene to be involved in ADCAs was
CACNA1A (MIM: 601011), encoding the P/Q-type
voltage-gated calcium channel. Small polyglutamine ex-
pansions, loss-of-function mutations, or missense variants
in this gene give rise to spinocerebellar ataxia type 6 (SCA6
[MIM: 183086]), episodic ataxia type 2 (MIM: 108500), or
familial hemiplegic migraine type 1 (MIM: 141500).5,6
Knockdown of the fibroblast growth factor gene FGF14
(MIM: 601515), associated with SCA27 (MIM: 609307), re-
duces calcium currents in granule cells.7 Mutations in
other ion-channel genes, including the voltage-gated
potassium-channel genes KCNC3 (MIM: 176264; associ-
ated with SCA13 [MIM: 605259])8 and KCND3 (MIM:
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the ligand-gated ion-channel genes ITPR1 (MIM: 147265;
associated with SCA15 [MIM: 606658]) and GRID2 (MIM:
602368),1,11,12 have also been described. All these findings
converge to emphasize the importance of ion balance,
notably that of calcium ions, in cerebellar physiology.13
In this paper, we report three pedigrees in which ADCA
segregates with a recurrent mutation inducing an amino
acid change in the voltage sensor S4 segment of domain
IV in Cav3.1, a T-type calcium channel protein encoded
by CACNA1G (MIM: 604065). We present electrophysio-
logical in vitro evidence that this p.Arg1715His variant
(GenBank: NM_018896.4) alters the channel activity and
thus shifts its steady-state activation curve toward more-
positive values and changes its inactivation slope constant.
In an in silico model of deep cerebellar nuclei (DCN) neu-
rons, we established that decreased excitability is linked to
these altered parameters. Altogether, we describe a mono-
genic disease linked to CACNA1G mutations; confirm the
implication of Cav3.1 channels, which are highly ex-
pressed in Purkinje cells (PCs) and DCN neurons, in cere-
bellar physiology; and strengthen the gathering of
evidence toward the prominence of calcium levels in CA
pathophysiology.
Families AAD-SAL-233, AAD-GRE-319, and AAD-SAL-
454, along with more than 500 other ADCA-affected
pedigrees, were part of the Spastic Paraplegia and Ataxia
(SPATAX) network cohort. Affected members and relatives
were examined, and blood was taken after informed con-
sent was obtained according to French legislation (Paris
Necker ethics committee approval [RBM 01-29 and RBM
03-48] to A. Brice and A.D.). All clinical data are summa-
rized in Table 1. The age of onset varied widely from 9 to
78 years; gait instability was the major manifesting symp-
tom (in nine of ten individuals). Even after decades of pro-
gression, the disability and symptoms remained mild to
moderate, indicating stable cerebellar involvement. Ocular
signs, including saccadic pursuit, horizontal nystagmus,
and transient diplopia, were often noted (in seven of ten
individuals). Interestingly, pyramidal signs, ranging from
reflex pyramidal syndrome to spastic gait, were present
in five of ten individuals. Of note, depression was reported
in three of ten individuals, and cognitive impairment was
observed in two of ten individuals. When performed (in
five individuals), MRI revealed predominantly vermian
cerebellar atrophy and a normal pons (Figure S1).
Individual AAD-SAL-233-14 (III-9 in Figure 2) had pro-
vided written informed consent for brain donation. She
died at age 83. The left brain hemisphere was examined,
whereas samples from the right hemisphere were frozen
and kept in the brain bank GIE Neuro-CEB (BioResource
Research Impact Factor number BB-0033-00011) and
declared to the Ministry of Research and Higher Education
as required by French law. The brain bank has been
officially authorized to provide samples to scientists (agree-
ment AC-2007-5). Macroscopically, the cerebellar hemi-
sphere and the vermis were, respectively, mildly and
severely atrophic. The cerebral cortex appeared normal.The AmericanMicroscopically, the volume of the cerebellar white matter
was reduced. Bergmann gliosis and empty baskets were ev-
idence of PC loss, more prominent in the vermis. In the
granular layer, the number of glomeruli was decreased.
The cellular density was increased in the molecular layer,
which appeared loosened (Figure 1). Unusually abundant
polyglucosan bodies were observed in all cerebellar layers.
The neuronal density in the dentate nucleus was normal,
as was the density of myelinated axons in the hilus. There
was no neuronal loss in the pontine nuclei. The number of
neurons was reduced in the inferior olive, which appeared
gliotic. The substantia nigra was normal.
Microscopic evidence of Alzheimer disease (AD [MIM:
104300]), including amyloid deposits in the cerebral cor-
tex, the hippocampus, and the basal ganglia (Thal phase
314), was also observed. Tau-positive neurofibrillary tan-
gles, neuropil threads, and senile plaque coronae were
seen in the entorhinal cortex and hippocampus. Associa-
tive cortices were mildly affected, and primary cortices
were spared (Braak stage V15).
Polyglutamine and C9orf72 (MIM: 614260) expansions
had previously been excluded in all three index subjects
via classic procedures. Linkage analysis was performed in
family AAD-SAL-233 (Figure S2). Six major putative loci
were detected, andmaximal multipoint LOD scores ranged
from þ1.579 to þ2.279. Whole-exome sequencing was
performed in individuals AAD-SAL-233-15 (III-10 in
Figure 2) and AAD-SAL-233-25 (IV-16 in Figure 2), and
achieved 85%–87% 303 coverage, through enrichment
capture using the SureSelect All Exon 50 Mb Kit (Agilent)
and subsequent paired-end 75 bp massive parallel
sequencing in a HiSeq 2000 sequencer (Illumina) (Table
S1). Results were analyzed according to the following
criteria: (1) the effect on the coding sequence of an
established protein-coding gene, (2) the heterozygous
state in affected individual 25 and absence from
healthy individual 15, (3) the location within the non-
excluded loci, and (4) a frequency under 0.1% in
public databases (dbSNP137, NHLBI Exome Sequencing
Project Exome Variant Server [EVS], and the Exome
Aggregation Consortium [ExAC] Browser). Sanger valida-
tion and segregation analysis in all family members
led to the identification of two candidate variants: a
chr10: g.95372766G>A (c.284G>A; p.Arg95His) change
(GenBank: NM_006204.3) in PDE6C (MIM: 600827) and
a chr17: g.48694921G>A (c.5144G>A; p.Arg1715His)
change (GenBank: NM_018896.4) in CACNA1G (MIM:
604065) (Figure 2; Table S2). Of note, PDE6C is
much more tolerant to missense variations than
CACNA1G, as estimated by Samocha et al.,16 in that
it has an observed-to-expected ratio of 236:261.5
(Z score ¼ 0.77), whereas that of CACNA1G is 598:903.6
(Z score ¼ 4.97).
We then screened ADCA index subjects for variants in
CACNA1G (n ¼ 479), PDE6C, and genes previously
involved in ADCA (n ¼ 384) by using amplicon-based
panel-sequencing techniques, either with conventionalJournal of Human Genetics 97, 726–737, November 5, 2015 727
PCR amplification followed by GS Junior (Roche)
sequencing (n ¼ 95) or with microfluidic PCR amplifica-
tion (Fluidigm Access Array) followed by MiSeq (Illumina)
sequencing (n ¼ 384) according to the manufacturers’ pro-
tocols (Table S3). Results were analyzed according to the
above-mentioned criteria. Two index subjects, AAD-GRE-
319-12 (II-2 in Figure 2) and AAD-SAL-454-10 (III-1 in
Figure 2), harbored the same CACNA1G c.5144G>A
(p.Arg1715His) variant (GenBank: NM_018896.4). No
recurrence of the above-mentioned PDE6C variant was
observed. All detected PDE6C variants, reported in Table
S4, were present in public databases.
No conventional mutations in genes previously in-
volved in ADCA were found in AAD-GRE-319-12 (II-2 in
Figure 2). AAD-SAL-454-10 (III-1 in Figure 2) also harbored
a variant of unknown significance (American College of
Medical Genetics and Genomics class 3) in SPTBN2
(MIM: 604985; associated with SCA5 [MIM: 600224]),
chr11: g.66455764G>A (c.6250G>A; p.Glu2084Lys)
(GenBank: NM_006946.2), not located within the
spectrin repeats, as previously described for all SPTBN2
mutations.17 It was reported at the heterozygous state in
one individual in the EVS and one other individual in
the ExAC Browser; almost all in silico prediction
software predicted it to be tolerated (data not shown). No
recurrence was observed in the other 383 index individuals
tested.
Segregation of theCACNA1G c.5144G>A (p.Arg1715His)
variant was established in two additional affected members
of family AAD-GRE-319 (Figure 2). Other individuals
harbored various CACNA1G variants (Table S5); however,
their pathogenic effects could not be ascertained because
of the lack of affected individuals for segregation studies,
genetic elements suggesting deleterious effects, or electro-
physiological anomalies (Table S6). Analysis of flanking
variants identified two homozygous variants in the
CACNA1G region (chr17: g.48652875A>G and chr17:
g.48655493A>G) in individual AAD-SAL-454-10 (III-1 in
Figure 2); these were absent in AAD-SAL-233-25 (IV-16
in Figure 2) and heterozygous in AAD-GRE-319-12 (II-2 in
Figure 2), excluding a common founder effect for all three
families.
We hence focused on the CACNA1G variant and not on
the PDE6C one because of strict co-segregation with the
disease, absence in public databases, more concordant
pathogenicity prediction scores, slightly higher conserva-
tion scores (Table S2), lower tolerance to missense varia-
tion, extremely high expression in the cerebellum,18–20
and the previous implication of CACNA1A, as well as other
ion-channel genes, in cerebellar ataxias.
To study the effect of the p.Arg1715His variant on the
electrophysiological characteristics of Cav3.1, we intro-
duced the c.5144G>A mutation into the cDNA of the hu-
man Cav3.1 channel (isoform 5, UniProt: O43497-121) by
site-directed mutagenesis (QuikChange Lightning Site-
Directed Mutagenesis Kit, Agilent Technologies). The WT
and mutant cDNA constructs were then transfected into728 The American Journal of Human Genetics 97, 726–737, NovembHEK239T cells, and macroscopic currents were recorded
by whole-cell patch-clamp techniques. Figure 3A shows
typical recordings of the calcium current generated by
these channels. Several differences between the WT and
the p.Arg1715His channel were observed. Notably, the
aberrant channel exhibited a significant shift of the
steady-state activation curve toward more-positive mem-
brane-potential values. The half-activation potential
changed from 47.20 5 0.65 mV (n ¼ 18) for the WT to
43.275 0.73 mV (n ¼ 16) for the p.Arg1715His channel
(p < 0.001) (Figure 3B). The steady-state inactivation curve
was also affected. Although the half-inactivation potential
was unchanged (70.91 5 0.48 mV [n ¼ 15] for the WT
versus 70.68 5 0.36 mV [n ¼ 16] for p.Arg1715His), the
slope factor was significantly higher for the aberrant chan-
nel (5.39 5 0.11 mV [n ¼ 16]) than for the WT (4.29 5
0.07mV [n¼ 15]) (p< 0.0001). As a consequence, the win-
dow current also shifted toward more-positive membrane
potentials (Figure 3D). No significant change was observed
in current density or other biophysical properties, such as
activation and inactivation kinetics (Figures 3E and 3F), re-
covery from inactivation (Figure 3G), or deactivation ki-
netics (Figure 3H). T-type calcium channels, especially
Cav3.1, are highly expressed in cerebellar neurons,
including DCN neurons.24 To determine the functional
consequences that the p.Arg1715His change could have
on firing, we used a DCN computer model22 with both
excitatory and inhibitory inputs from 150 mossy fibers
and 450 PC synapses, respectively. Introduction of our
experimental parameters for the steady-state activation
and inactivation curves in this model revealed alteration
of DCN firing properties. Notably, the p.Arg1715His
change led to a diminution of the number of spikes per
burst (four spikes compared to five for the WT; Figure 3I)
and a delayed onset of burst firing, thus increasing the in-
terval between the bursts (Figure 3I). These results suggest
that the p.Arg1715His channel is responsible for a decrease
in the neuronal excitability.
The Cav3.1 channel belongs to the family of voltage-
gated calcium channels (VGCCs), a large family divided
into two main subgroups: (1) low-voltage activated (LVA)
VGCCs, also known as T-type channels, comprising the
Cav3.1 (encoded by CACNA1G), Cav3.2, and Cav3.3 iso-
forms; and (2) high-voltage activated (HVA) VGCCs,
further divided into L-type, P/Q-type, N-type, and R-type
channels depending on their sensitivity to pharmacolog-
ical agents.25–27 VGCCs are major actors regulating the cal-
cium entry into neurons and, in turn, play predominant
roles in the regulation of membrane potential and also in
the modulation of calcium signaling pathways, such as
neurite outgrowth,28 calcium-dependent gene transcrip-
tion, neurotransmitter release, or regulation of enzymes
such as protein kinase C,27 whose gamma subunit is asso-
ciated with spinocerebellar ataxia 14 (MIM: 05361) when
mutations occur in PRKCG (MIM: 176980).29 The variety
of coexisting subtypes and isoforms allows the establish-
ment of highly specific neuronal firing patterns.27,30,31er 5, 2015
Table 1. Clinical Characteristics of Affected Individuals from Families AAD-SAL-233, AAD-GRE-319, and AAD-SAL-454
Individuala
AAD-SAL-
233-9
(III-3)
AAD-SAL-
233-14
(III-9)
AAD-SAL-
233-20
(IV-4) AAD-SAL-233-25 (IV-16)
AAD-SAL-233-45
(V-5)
AAD-SAL-
233-46
(V-6) AAD-GRE-319-12 (II-2)
AAD-GRE-
319-13
(III-2)
AAD-
GRE-
319-14
(II-1)
AAD-SAL-454-10
(III-1)
Sex female female male female female female female male female male
Age at
onset
(years)
20 68 41 9 19 18 37 40 78 30
Symptoms
at onset
vertigo gait
instability
gait
instability
gait instability, vertigo gait instability gait
instability
gait instability gait
instability
gait
instability
gait instability
Exam Results
Exam year 1998 2012 1999 1999 2012 2001 2012 2009 1998 2012 2015 2015 2015 2000 2010
Age at
exam
(years)
73 82 43 42 53 28 39 32 57 69 74 51 79 37 47
Disease
duration
(years)
53 14 2 33 44 9 20 14 20 32 37 11 1 7 17
Disability
score
(SDFS)b
4/7 4/7 1/7 3/7 3/7 2/7 2/7 2/7 4/7 5/7 5/7 3/7 2/7 2/7 3/7
Cerebellar
syndrome
(SARA
score)
moderate yes mild mild yes (20/40) yes mild
(12.5/40)
mild yes yes (21/40) yes (20.5/40) mild
(12/40)
mild
(4/40)
yes yes (12/40)
Cerebellar
signs
in ULs
yes NA no no yes no yes yes no mild mild mild no no yes
Dysarthria severe no yes yes yes no yes yes yes moderate moderate moderate no yes yes
Ocular
signs
limited
upward
gaze
NA none intermittent
diplopia
hypometric
saccades,
square waves
saccadic
pursuit
hypometric
saccades
none saccadic
pursuit
saccadic
pursuit
saccadic
pursuit,
diplopia,
strabism
saccadic
pursuit
saccadic
pursuit
nystagmus nystagmus
LL reflexes þ ( ankle) NA þþ þþ þþ þ þ N þ N þ N N N N
Spastic gait no NA mild mild mild NA no no NA no mild no no no no
UL reflexes N NA þþ þþ þþ N þ N þ N þ N N N N
(Continued on next page)
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Table 1. Continued
Individuala
AAD-SAL-
233-9
(III-3)
AAD-SAL-
233-14
(III-9)
AAD-SAL-
233-20
(IV-4) AAD-SAL-233-25 (IV-16)
AAD-SAL-233-45
(V-5)
AAD-SAL-
233-46
(V-6) AAD-GRE-319-12 (II-2)
AAD-GRE-
319-13
(III-2)
AAD-
GRE-
319-14
(II-1)
AAD-SAL-454-10
(III-1)
Babinski
sign
no NA no yes yes no no no unilateral no no no no yes no
Decreased
vibration
sense at
ankles
yes NA yes no no no yes no no mild mild no mild no yes
Urinary
symptoms
urgency NA no no incontinence no no no no no urge y no; erectile
dysfunction
urgency urgency incontinence
Other signs no NA no no;
myokymia
orbicularis
postural UL
and head
tremor
no no no;
myokymia
orbicularis
scoliosis,
swallowing
difficulties
myokymia
orbicularis
dysp gia,
dysa ria
dysphagia,
dysarthria
no no swallowing
difficulties,
psoriasis
Mood or
cognitive
impairment
no Alzheimer
disease
depression depression no no N no no no no no no MMS 25/30,
depression
no
Cerebral MRI NA NA vermian
atrophy less
foliation of the
hemispheres,
N-acetyl-
aspartate
decrease
vermian
atrophy
NA vermian
atrophy
NA NA vermian
atrophy
NA cere lar
atro y
(ver nþþ),
whi atter
hyp ignals
NA NA vermian
atrophy
cerebellar
and
brainstem
hypoplasia
and atrophy
Abbreviations are as follows: LL, lower limb; MMS, mini mental state; N, normal; NA, not available; SARA, scale for the assessment and rating of ataxia; SD , spinocerebellar degeneration functional score; UL, upper limb.
aPersonal numbers are followed by pedigree numbers according to Figure 2.
bScores are as follows: 0, no functional handicap; 1, no functional handicap but signs at examination; 2 (mild), ability to run; 3 (moderate), inability to run (severe), unlimited walking with one stick; 5, ability to walk with
two sticks; 6, inability to walk and wheelchair requirement; 7, confinement to bed.
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Figure 1. Neuropathological Examina-
tion of the Cerebellum
H&E staining in (A and B) individual AAD-
SAL-233-14 (III-9 in Figure 2) and (C andD)
a control individual.
(A and C) Granular layer of the cerebellum.
The black arrows in (C) point to normal
glomeruli; normal glomeruli cannot be
identified in (A).
(B and D) Purkinje cell (PC) layer. Four
normal PCs are visible in (D), and one of
them is indicated by a black arrow; PC
loss is severe in (B) such that only the pro-
cesses of the basket cells are visible (‘‘empty
baskets,’’ black arrows). Note the additional
layer composed of Bergmann glia (white
arrows). The asterisks in (B) and (D) indi-
cate the molecular layer, which appears
loosened in (B).T-type Cav3 calcium channels differ from HVA-VGCCs by
their ability to be activated and inactivated at low voltages
(near the resting membrane potential), their faster
recovery from inactivation, their slower deactivation, and
a characteristic window current occurring in the range of
the resting membrane potential of neurons.32,33 In this
respect, they act as pacemakers and excitability regula-
tors,27 allowing cells to be depolarized at the needed
membrane potential for other channels’ activation. This
window current is also essential for the regulation of the
intracellular calcium concentration.34 In neurons, they
have two essential behaviors: triggering a burst action
potential after a low-threshold calcium spike26,33 and
rebound burst firing.27,32,33 Of the three Cav3 isoforms,
Cav3.1 is highly expressed in cerebellar neurons, as well
as thalamic relay neurons,18,20 where it plays a major role
in the establishment of the slow (<1 Hz) sleep oscillations
of non-rapid-eye-movement (REM) sleep.32 Gain-of-func-
tion variants are thought to participate in the spike-and-
wave discharges of thalamocortical neurons in absence ep-
ilepsy (MIM: 611942) through enhancement of thalamic
oscillatory activities.18,26,35,36
In the cerebellum, a comprehensive study of Cav3
expression in neurons revealed that their specific patterns
are correlated with various electrophysiological pheno-
types.31 In situ hybridization studies described CACNA1G
mRNA in both PCs and DCN neurons.20,37 In the DCN,
Cav3.1 is predominantly expressed in a subset of large neu-
rons exhibiting a strong ability to generate rebound burst
firing after hyperpolarization.31,38 Pharmacological evi-
dence has confirmed that these rebound bursts are medi-
ated by T-type calcium channels.39 They appear to be
physiologically relevant and consistent with a response
to inhibitory input from PCs.40 Their characteristics result
from interplay between T-type channels and hyperpolar-The American Journal of Human Genization-activated cyclic-nucleotide
(HCN) channels.24,40 In PCs, all three
subtypes of Cav3 are expressed.31
Cav3.1 was found at the cell bodyand at the synapse between parallel fibers (PFs) and
PCs.19 At this synapse, Cav3 channels interact with inter-
mediate-conductance calcium-activated potassium (IKCa)
channels to suppress the temporal summation of back-
ground excitatory postsynaptic potentials from PFs
through afterhyperpolarization.24,41 This is essential to
allow the detection of sensory-relevant high-frequency
inputs.24,41 Finally, PC burst firing was shown to rely on
P/Q-type calcium currents. In addition, T-type channels
interact with large-conductance calcium-activated potas-
sium (BK) channels to determine the firing rate, burst dura-
tion, and interburst interval.42 Therefore, T-type channels,
including Cav3 isoforms and specifically the Cav3.1 iso-
form, have major roles in the PF-PC-DCN signal process-
ing. Of note, histologically, the neuronal density appeared
normal in the dentate nucleus of our affected individual;
marked PC loss was observed.
In mice, which show 93% Cav3.1 amino acid sequence
identity with humans, no spontaneous Cacna1gmutations
have been reported; however, several models have been
generated.Cacna1g-null mice have normal growth, normal
brain pathology, and no overt neurological phenotype;43
in particular, they have no motor defects.44 However,
they present with a non-REM sleep disturbance,45 are resis-
tant to pharmacologically induced absence seizures,43
show attenuated neuropathic pain,46 and show brady-
cardia and slowed atrioventricular conduction.47 The
only cerebellar anomaly linked to Cacna1g inactivation
was a loss of PCs in double-mutant mice lacking
both Cav3.1 and the alpha-1 GABA-A receptor.44
Compared to mice lacking only the GABA-A receptor,
this mouse model showed exacerbated motor defects,
including tremor. Conversely, transgenic mice overex-
pressing Cav3.1 showed spontaneous spike-and-wave dis-
charges associated with behavioral arrest.18etics 97, 726–737, November 5, 2015 731
Figure 2. Segregation of the p.Arg1715His Change in ADCA-Affected Pedigrees and Alignment of Cav3.1 Orthologs and Paralogs
(A) Pedigrees of ADCA-affected families with the p.Arg1715His change. The numbers of affected individuals tested are as follows: six in
AAD-SAL-233, three in AAD-GRE-319, and one in AAD-SAL-454. All affected, but no unaffected, individuals harbor the variant in the
heterozygous state.
(legend continued on next page)
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In human pathology, the role of T-type VGCCs has only
been partially elucidated. In particular, no monogenic dis-
ease has clearly been linked to T-type channel gene muta-
tions until now.26,48 CACNA1H (MIM: 607904), encoding
Cav3.2, is implicated inabsence epilepsy49–51 in that several
mutations lead to increased activity of the channel.52 How-
ever, inmany cases, the variant induces susceptibility to sei-
zures rather than having a monogenic causative effect.26,50
As for CACNA1G, some variants have been described in
idiopathic generalized epilepsy (MIM: 600669);53 many, if
not all, of them appear to be risk-factor variants and not
causative mutations. CACNA1G was also associated with
autism spectrum disorder (MIM: 209850), but the associa-
tion was too weak to fully explain the odds ratio.54 Finally,
a large study on intellectual disability identified a homozy-
gous CACNA1G frameshift variant in three siblings with
associated cataracts but no reported cerebellar ataxia.55
Despite its predominant expression in PCs and DCN
neurons, CACNA1G was never implicated by itself in cere-
bellar dysfunction. In three independent ADCA-affected
families, we describe the recurrent p.Arg1715His variant
in Cav3.1. There are strong genetic arguments in favor of
the deleteriousness of this variant: (1) the concordance of
all in silico pathogenicity predictions; (2) the variant’s
absence in all examined public databases (including
more than 60,000 exomes); (3) amino acid conservation
in all orthologs, paralogs, and S4 segments of all four
domains of the protein; (4) the variant’s location within
a putatively linked locus (Figure S2); (5) the absence of
pathogenic variants in all genes previously involved in
ADCA; (6) the recurrence of the variant in three pedigrees
in which a common founder effect was excluded; (7) per-
fect segregation in both pedigrees where it could be veri-
fied; and (8) the variant’s location within a functionally
important domain of the protein: the voltage sensor S4
segment. Importantly, in vitro studies showed that the
variant alters electrophysiological characteristics of the
channel, including activation at more-positive voltages,
an increased slope factor of the steady-state inactivation
curve, and consequently, a shift of the window current
toward more-positive potentials. Minimal alterations in
T-type VGCC properties can lead to marked alterations in
firing dynamics.56 Simulating the activity of a DCN
neuron carrying either WTor p.Arg1715His Cav3.1 param-
eters also revealed a difference in burst firing, suggesting
that the aberrant channel causes reduced neuronal excit-
ability. Because the activity of DCN neurons and cerebellar
PCs is involved in movement behavior,57,58 our findings
suggest that the p.Arg1715His change in Cav3.1 could
affect motor control by altering DCN activity.(B) Chromatograms show the mutation in individuals AAD-SAL-233
(C) A schematic representation of Cav3.1 shows its organization i
segment S4 contains many positively charged amino acids, such as
change is located in segment S4 of domain IV.
(D and E) Alignment of orthologs (D) and paralogs (E) shows that th
species, T-type channels, and domains.
The AmericanAll together, these elements establish CACNA1G muta-
tions as a monogenic cause of ADCA. The p.Arg1715His
variant is recurrent and has a relatively high frequency of
almost 0.6% in our cohort after exclusion of polyglut-
amine expansions (~0.3% of all ADCA). The other variants
detected (Table S5) could be benign polymorphisms, vari-
ants that potentiate other ion-channel variants (such as
loss-of-function CACNA1A mutations), or causative muta-
tions. Further investigations will be needed to elucidate
their effects.
Interestingly, the clinical picture in the families we
describe does not include any form of epilepsy. Indeed,
the p.Arg1715His variant induces a shift of activation to-
ward positive voltages, whereas epilepsy-associated T-type
channel variants are classically associated with a gain
of function through faster activation, negative shift of
steady-state activation and inactivation properties, or
increased protein amounts.26,52 In agreement with these
observations, CACNA1G-null mice are resistant to induced
seizures.43 Expectedly, a positive shift in activation proper-
ties, as in our families, should be protective or have no
effect.
It is of note that, in family AAD-SAL-233, individual 14
(III-9 in Figure 2) presented with both clinical signs and
pathological characteristics of AD. Another family member
presented with ataxia and Alzheimer-type dementia, but
no DNA was available for sequencing, and the brain was
not available. CACNA1G downregulation and Cav3.1 inhi-
bition were recently correlated with altered APP (amyloid
precursor protein) processing and, consequently, the
occurrence of AD markers in microarrays of human tissue,
mice, and cellular models.59 We could not determine
whether the p.Arg1715His change is related to AD in this
individual. Nevertheless, the co-occurrence of AD at 83
years of age is not unexpected.
It is interesting to note that the variant we describe,
p.Arg1715His, modifies a highly conserved arginine in
the S4 segment in domain IV of the channel. All T-type
channels share a common general membrane topology
with four domain repeats, each including six transmem-
brane segments (S1–S6). S4 segments, through their posi-
tive arginine residues, are considered the voltage-sensing
elements, and their alteration is expected to affect the
voltage dependency of the channel. A systematicmutagen-
esis study in Cav3.1 showed that loss of the outermost argi-
nine residues in the voltage sensor S4 segment of domain
IV affects the steady-state inactivation curve.60 Our results
establish that Arg1715, the third outermost arginine in
domain IV (R3), also plays a role in Cav3.1 gating by shift-
ing the steady-state activation curve and changing the-9 (III-3), AAD-GRE-319-12 (II-2), and AAD-SAL-454-10 (III-1).
n four domains, each containing six transmembrane segments;
arginine, and is therefore the voltage sensor. The p.Arg1715His
e arginine residues in Cav3.1 are very highly conserved across all
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Figure 3. Electrophysiological Analysis of WT and p.Arg1715His Cav3.1 Calcium Channels
(A) Current traces obtained with wild-type (WT) and p.Arg1715His channels at various membrane potentials (90,80,70,65,60,
55, 50, 45, 40, 35, 30, 25, and 20 mV) and from a holding potential of 100 mV. Notice the red trace (50 mV), which
shows a smaller current for the p.Arg1715His channel (36% of the maximum current) than for the WT (54%)
(B) Averaged current-voltage relationships from traces in (A). The normalized conductance-voltage curve was fitted with a Boltzmann
equation: I/Imax ¼ Gmax(Vm  Erev)/(1 þ exp(V1/2  Vm)/k).
(C) Steady-state inactivation curves. The curves were fitted with I/Imax ¼ 1/(1 þ exp(Vm  V1/2)/k).
(D) Availability of calcium currents (mean steady-state activation and inactivation curves). The steady-state activation curves were fitted
with a Boltzmann equation, G/Gmax ¼ 1/(1 þ exp(V1/2  Vm)/k), where G was calculated as follows: G ¼ I/(Vm  Erev).
(E and F) Time constant of inactivation (t inact) and activation (t act) kinetics. Fitting the traces showed in (A) with a double exponential
function produced the values shown.
(G) Recovery from short-term inactivation according to a two-paired-pulse protocol.
(H) Deactivation kinetics (t deact).
(I) DCN neuron firing was simulated with the steady-state activation and inactivation values obtained for the WT (black) and the
p.Arg1715His (red) channels. The DCN model used was developed by Luthman et al.22 with the NEURON simulation environment
(legend continued on next page)
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slope of the steady-state inactivation curve. This is consis-
tent with the observation, in Cav3.2, that the equivalent
arginine-to-histidine change (R3) also induces a positive
shift in the steady-state activation curve of the protein at
pH 6.561; this would be expected from eliminating one of
the arginines in segment S4.
In conclusion, we report three ADCA-affected families in
whom a common variant affecting an arginine residue in
the voltage sensor S4 segment of domain IV in Cav3.1 seg-
regates with the disease. Genetic and electrophysiological
evidence support the pathogenicity of this variant. These
results underscore the prominent role of Cav3.1-mediated
calcium currents in cerebellar physiology, whereas previ-
ous reports on dysfunctions of this channel have focused
on thalamocortical relay neurons. We describe a mono-
genic disease caused by alteration of T-type currents. Our
results also underscore the important role played by the
S4 segment of domain IV in the gating properties of
Cav3.1. Finally, we provide further evidence of the impor-
tance of ion-channel function in the physiopathology of
cerebellar ataxia and, in particular, of calcium-related
pathways.Supplemental Data
Supplemental Data include three figures and six tables and can be
found with this article online at http://dx.doi.org/10.1016/j.ajhg.
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